NCT05153837

Brief Summary

Human digestive system physiologically ensures the absorption of oral water and hydration of the human body. Water is quickly absorbed by the digestive tract with a peak between 15 and 20 minutes. It has demonstrated that oral water remains the best hydration solution that have an effect on plasma volume expansion and cardiovascular system during exercise. While the cardiovascular effect of fluid expansion by saline serum is well known (venous return, preload and cardiac output), effect of oral water varies in the literature depending on the physiological state of the patient and the clinical state. Thus, the investigators aim to investigate oral water effects on fluid responsiveness, regional blood flow and microcirculatory changes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
59

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 30, 2021

Completed
Same day until next milestone

Study Start

First participant enrolled

November 30, 2021

Completed
10 days until next milestone

First Posted

Study publicly available on registry

December 10, 2021

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 28, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 28, 2023

Completed
Last Updated

May 28, 2025

Status Verified

May 1, 2025

Enrollment Period

1.7 years

First QC Date

November 30, 2021

Last Update Submit

May 22, 2025

Conditions

Keywords

intravenous fluidspharmacodynamicsfluid therapyfluid responsivenessfluid challenge

Outcome Measures

Primary Outcomes (1)

  • number of fluid responders 30 minutes after fluid expansion

    30 minutes after fluid expansion

Study Arms (2)

oral water

EXPERIMENTAL

Experimental group: oral administration of 500 ml of water.

Other: oral water

intravenous

ACTIVE COMPARATOR

Active comparator: Administration of 500 mL of saline (NaCl 0.9%) administered by the venous route

Other: saline intravenous administration

Interventions

Administration of 500 mL of saline (NaCl 0.9%) administered by the venous route

intravenous

500 ml oral water

oral water

Eligibility Criteria

Age18 Years - 30 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy volunteer subject between 18 and 30 years old
  • patient with a regular sinus rhythm
  • Echogenic subject.
  • Fasting of solid and liquid since 8 h
  • Subject in regular sinus rhythm.
  • Written consent signed.

You may not qualify if:

  • Any known cardiac, renal or endocrine pathology.
  • Arrhythmia rhythm disorder by atrial fibrillation
  • Pregnant or nursing woman.
  • Pathology versus indicating Nacl administration.
  • Person under tutors or curators or deprived of liberty.
  • Person not affiliated to a social security scheme.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Amiens-Picardie

Amiens, 80054, France

Location

MeSH Terms

Interventions

Water

Intervention Hierarchy (Ancestors)

HydroxidesAlkaliesInorganic ChemicalsAnionsIonsElectrolytesOxidesOxygen Compounds

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 30, 2021

First Posted

December 10, 2021

Study Start

November 30, 2021

Primary Completion

August 28, 2023

Study Completion

August 28, 2023

Last Updated

May 28, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations